Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?
Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume.
Cellebrite has a strong competitive advantage as the gold standard in digital forensics, making it difficult for new players to replicate or displace. CLBT serves a mission-critical function in digital investigations for law enforcement, with a majority of revenue coming from subscriptions. Up/cross selling opportunities and penetration into adjacent functions are key drivers for CLBT's future earnings growth.
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2024 Earnings Call Transcript May 23, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Shaul Eyal - TD Cowen Jonathan Ho - William Blair Mike Cikos - Needham Eric Martinuzzi - Lake Street Brian Essex - JPMorgan Jeff Van Rhee - Craig-Hallum Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share.